Definitive Contract 75N93023C00060

The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $299,995 firm fixed-price contract to Via Therapeutics, LLC, a small business located in Austin, Texas. The contract is for the development of low-cost, shelf-stable, patient-adaptable clofazimine mini-tablets to treat tuberculosis in pediatric patients. This contract supports Via Therapeutics' pharmaceutical research and development efforts related to...

Via Therapeutics, LLC has been awarded a firm fixed price definitive contract valued at $3,599,145 by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. This contract is set aside for small businesses and will support Phase I of Via Therapeutics' SBIR program efforts to develop an inhaled delivery method for clofazimine, an important drug for treating tuberculosis. The contract aligns with the agency's solicitation...

This is a $300,000 Firm Fixed Price contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Vitruvian Bio, LLC, a small disadvantaged woman-owned business. The contract is for a Small Business Innovation Research (SBIR) Phase I project to be completed by June 30, 2023. The award is associated with a larger SBIR solicitation that sought innovative research proposals from small businesses to...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $126,264 firm fixed price delivery order to the University of Texas Health Science Center of San Antonio under the In Vitro Assessments of Antimicrobial Activity indefinite-delivery/indefinite-quantity multiple award contract vehicle. This task order is for the determination of the in vitro inhibitory effect of experimental antibacterial substances against the...

This firm fixed price delivery order contract was awarded to the University of Texas Health Science Center at San Antonio (UTHSCSA) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The $1,589,216 award is for therapeutics testing in murine models of fungal infections under Task Order A86 of NIAID's Preclinical Models of Infectious Diseases 2017-2024 contract. As a prime contractor under this $146.3 million indefinite...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $208,965.00 firm fixed price delivery order to the University of Texas Health Science Center at San Antonio (UTHSCSA) to provide in vitro assessment for antimicrobial activity. This task order is part of a larger 7-year, $146.3 million indefinite delivery contract between NIAID and UTHSCSA to develop and refine small animal, non-human primate, and non-traditional animal models for evaluating candidate therapeutics and...

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), awarded a $13.6 million cost plus fixed fee delivery order contract to Leidos Biomedical Research, Inc. to support the Vaccine Research Center's (VRC) mission scope including research and development of vaccines and therapeutics for the prevention and treatment of diseases of human concern, including malaria, at their...

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The $99,299 cost-plus-fixed-fee delivery order was placed under the Therapeutics Against Infectious Diseases Phase 1 IDIQ contract, which funds Phase I clinical trials for therapeutic products targeting infectious diseases. The prime contractor is Dynport Vaccine Company LLC, a subsidiary of General Dynamics...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $24,324 firm fixed price purchase order to 10X Genomics, Inc. for unspecified products or services in support of the agency's research programs. The contract has a period of performance from September 26, 2023 through October 25, 2023 and will be performed in Pleasanton, California. This sole source award was set aside for total small businesses. No additional...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1,151,741.00 delivery order contract to the University of Texas Medical Branch at Galveston (UTMB) for preclinical research services related to infectious diseases. This contract is a task order under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery/indefinite quantity (IDIQ) contract. UTMB, a state controlled institution of...